Combating Maternal Opioid Misuse (MOM) Model
The Role of Innovation and Technology
States have an excellent opportunity with the recent CMS announcement of the Maternal Opioid Misuse (MOM) model – the next stage of CMS’ efforts to address the opioid crisis. The model focuses on addressing fragmentation in the delivery of care to Medicaid beneficiaries in an especially vulnerable population, specifically pregnant and postpartum women with opioid use disorder (OUD). Its goal is to improve quality of care and reduce costs for mothers and infants. A maximum of $64.6 million in grant funding is available to up to 12 state awardees over a five-year period.
Pregnant and postpartum mothers and their young children are especially at risk for a host of problems related to opioid misuse: preterm labor and delivery complications, a higher risk of preterm birth and low birth weight, ongoing malnourishment of mother and child, interpersonal violence, unmet social needs, and neonatal abstinence syndrome. The population and individual health risks are high, outcomes are poor, and the long-term costs, both social and economic, are high.
Watch this webinar to learn:
- Information about the MOM model and available funding
- Examination of the problem through a lens relative to maternal and child health
- Challenges associated with linking critical healthcare delivery across the continuum of care
- Evidence-based solutions for strengthening the delivery of integrated care with actual case examples
- How Relias can be a strategic partner to organizations for success under the MOM model
Dr. Joe Parks, PhD
Medical Director, National Council for Behavioral Health
Carol Clayton, PhD
Chief Translational Neuroscientist, Relias
Integrated Care Manager, Missouri Coalition for Community Behavioral Health